Please assess the completion status of the following clinical trial:

Trial Title: OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 65 or older~* High concerns or high risk of fall~* Ambulatory~Exclusion Criteria:~* Presence of an active wound infection on either of the foot and ankle~* Use of medication or a medical condition that may have unstable (fluctuate over time) or temporary (less than one month) impact on gait and balance~* Acute fractures on the foot~* Participant of an interventional study within the last 30 days~* Non-ambulatory or unable to stand without help or walk a distance of at least 1.8 m (\~six feet) without assistance~* Major foot amputation~* Unable or unwilling to participate in all procedures

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MBB AFO Group (Type: EXPERIMENTAL): This group will be provided with a pair of New Balance 813 shoes plus a custom made MBB AFO for the duration of the study.
- No MBB AFO Group (Type: ACTIVE_COMPARATOR): This group will be provided with a pair of New Balance 813 shoes for the duration of the study.

Based on this trial design, predict the completion outcome and termination type (if applicable).